MicroPort CardioFlow Medtech Corp. (HK:2160) has released an update.
MicroPort CardioFlow Medtech Corporation has announced an Extraordinary General Meeting (EGM) to be held on September 20, 2024, where shareholders will vote on the approval of an Equity Transfer Agreement with Shanghai MicroPort Medical. The meeting will take place in Shanghai, China, with arrangements made for proxy voting and the results to be publicly disclosed afterward. Shareholders are encouraged to attend or appoint proxies for this significant decision-making event.
For further insights into HK:2160 stock, check out TipRanks’ Stock Analysis page.
